PGY-2 Oncology Specialty Residency

The PGY-2 Oncology Specialty Residency at Grady Health System (GHS) is a one-year ASHP-accredited program that offers a diverse experience for residents. The university teaching hospital environment and unique patient population provides opportunities for great learning experiences. Residents collaborate with Grady staff, as well as attendings from Emory and Morehouse Schools of Medicine and fellows from Emory School of Medicine. Experiences include inpatient rotations, as well as outpatient experiences in the Georgia Cancer Center for Excellence, Edward C. Loughlin Radiation-Oncology Center, and the Ponce de Leon Center (Comprehensive HIV/AIDs facility). Other activities include involvement with clinical research, chemotherapy order creation and management in Beacon, guidelines, policies, formulary management, precepting, and didactic lectures.

Required Experiences (4-5 weeks per learning experience)

• Orientation/Oncology Practice Management
• Hematology I – Inpatient (malignant and benign)
• Oncology I – Inpatient
• Outpatient I (oncology, malignant hematology, and benign hematology)
• Hematology/Oncology Infusion Center
• Stem cell transplant – Inpatient (Outside hospital)
• Surgical Oncology, Radiation Oncology, Ponce de Leon Center (Comprehensive HIV/AIDs facility)

Longitudinal Experiences

• Oncology Practice Management
  • Protocol/policy development
  • Beacon treatment plans and EPIC order sets
  • Professional Development Seminars, Residency Research Advisory Committee Seminars, and Capstone at Emory School of Medicine
  • 4-hour shift (Monday-Friday) in Cancer Center Pharmacy.  Weekly for approximately the first 5 months of residency based on evaluation of ****.  Remainder of the residency, every other week.
  • Inpatient weekend chemo on-call from home.  Once per month, approximately starting November.
• Research Committee and Investigational Drug service
• Residency Project 1 & 2 (12 months, Flipped Research Project (Presentations may include Vizient, SERC, and or HOPA)
• On-Call/and Staffing (outside the Cancer Center)
  • 24-hour in-house Clinical On-Call Program (25 – 30 shifts, 12 months)
  • 4-hour Staffing shifts main inpatient pharmacy for residents coming from outside institutions (3-5 shifts)
  • Inpatient Pharmacokinetics coverage (5 or 6 months)
• Clinical Seminar (Grand Rounds) and Clinical Case (12 months)
  • 2 ACPE-accredited presentations

Elective Experiences (#5) (4-5 weeks per learning experience)

• Outpatient II (oncology, malignant hematology, and benign hematology)
• Palliative Care
• Sickle cell
• Research Month
• Pediatrics (Children’s Health care of Atlanta) *(based on site availability)
• Others based on resident needs or interests

Other Learning Experiences

• Teaching Certificate Program via Mercer University (if not completed during PGY1)
  • Experiential and Didactic Tracks
  • Precepting, Facilitation, Lecture, Teaching Philosophy

• Other teaching and presentation opportunities
  • Seminar or lecture
  • Precepting
  • Journal clubs
  • In-services
• Committee participation

• • Medication Use Evaluation

Core Preceptors (see bios on main residency page):

• Julianna Cebollero, PharmD, BCOP

• Takia McCormick, PharmD, BCOP

• Jennifer LaFollette, PharmD, BCOP

Recent Graduates 

Emily Lee, PharmD, BCOP
Clinical Pharmacy Specialist – Leukemia
MD Anderson Cancer Center, Houston, TX

Annalise Labatut, PharmD, BCOP
Oncology Clinical Pharmacy Specialist – Breast Oncology
Emory Healthcare, Winship Cancer Institute, Atlanta, GA

Haley Ellis Adams, PharmD, MBA, BCOP
Pharmacist Specialist – Transplant and Cellular Therapy
University of Tennessee Medical Center, Knoxville, TN

Julianna Cebollero, PharmD, BCOP
Clinical Pharmacist Specialist – Outpatient Hematology/Oncology; Grady Health System
Adjunct Instructor, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA

Recent projects presented at national meetings:

• Impact of parenteral hydromorphone versus morphine on length of stay in patients with sickle cell disease
• Medication adherence and socioeconomic disparities among patients with metastatic prostate cancer treated with first-line oral chemotherapy
• Impact of an oncology pharmacist chemotherapy review on near miss identification
• Impact of parenteral hydromorphone versus morphine on length of stay in patients with sickle cell disease
• The impact of prophylactic intrathecal chemotherapy on central nervous system relapse in patients with AIDS-related B-Cell lymphoma
• Evaluation of a Pharmacist-Developed Infusion Reaction Protocol for Parenteral Anticancer Therapy Administered in an Ambulatory Infusion Center

PhORCAS References

Submit four (4) references that will utilize the Standardized Reference form provided in PhORCAS. Three (3) references should be provided by residency preceptors and one (1) from the residency program director.

Questionnaire

Please answer the following questions and upload them to PhORCAS:

Maximum 2 pages.  Singled spaced.  Font size 12.

1. List the top three reasons you are specifically interested in the PGY2 Oncology Residency Program at Grady Health System and provide detailed examples from your personal experiences that demonstrate how this program will contribute to your personal and professional development.
2. Describe previous experience(s) when you went above and beyond to address a health disparity or barrier to care for a patient?
3. Describe a time when you had to solve a problem with limited resources. How did you approach the situation, and what was the outcome?
4. Describe your most challenging PGY1 rotation or experience highlighting what made it challenging and how you addressed those difficulties.
5. When will you complete your PGY-1 training?

Applicants invited for an on-site interview in January or February and will be required to present a professional presentation on a topic related to clinical pharmacy practice (may present residency research project if some data collection and analysis has been completed).

For additional questions, please contact Dr. Jennifer LaFollette, Director of the Oncology Specialty Residency program, at (404) 489-9182 or by e-mail at [email protected].